Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/7/26 16:50 | 4/6/26 | VIR | Health | BioPrd | Biological Products, (No Diag | De Backer Marianne | CA | DO | P,CEO | 3 | S.d | -947 | 8.90 | 0 | -106 | 1,089 | D | |||||||||||||||
4/2/26 10:46 | 4/1/26 | VIR | Health | BioPrd | Biological Products, (No Diag | Sato Vicki L | CA | D | 5 | S.d | -1,055 | 7.00 | 0 | -151 | 1,144 | D | ||||||||||||||||
3/24/26 16:35 | 3/23/26 | VIR | Health | BioPrd | Biological Products, (No Diag | Sabatini Brent | CA | O | SVP, Chi | 4 | S.d | -110 | 8.76 | 0 | -13 | 71 | D | |||||||||||||||
2/26/26 16:55 | 2/24/26 | VIR | Health | BioPrd | Biological Products, (No Diag | O'Byrne Jason | CA | O | EVP,CFO | 2 | S.d | -31 | 8.37 | 0 | -4 | 164 | D | |||||||||||||||
2/26/26 16:55 | 2/24/26 | VIR | Health | BioPrd | Biological Products, (No Diag | Eisner Mark | CA | O | EVP,Chie | 2 | S.dm | -50 | 8.85 | 0 | -6 | 158 | D | |||||||||||||||
2/26/26 16:54 | 2/24/26 | VIR | Health | BioPrd | Biological Products, (No Diag | De Verneuil Vanina | CA | O | EVP,GC,C | 2 | S.dm | -197 | 9.28 | 0 | -21 | 130 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |